Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

ClinicalTrials.gov ID: NCT01161615

Public ClinicalTrials.gov record NCT01161615. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 9:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder.

Study identification

NCT ID
NCT01161615
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MEDRx USA, Inc.
Industry
Enrollment
350 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
14 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2010 (Type not available)
Primary completion
Jun 2011 (Actual)
Completion
Jun 2011 (Actual)
Last update posted
Jan 17, 2018

2010 – 2011

United States locations

U.S. sites
35
U.S. states
17
U.S. cities
34
Facility City State ZIP Site status
Not listed Chandler Arizona 85224 —
Not listed Phoenix Arizona 85050 —
Not listed North Little Rock Arkansas 72114 —
Not listed Chico California 95929 —
Not listed Mission Hills California 91345 —
Not listed Palm Springs California 92262 —
Not listed San Diego California 92120 —
Not listed Aurora Colorado 80014 —
Not listed Colorado Springs Colorado 80907 —
Not listed Denver Colorado 80239 —
Not listed Daytona Beach Florida 32114 —
Not listed Fort Lauderdale Florida 33334 —
Not listed Gulf Breeze Florida 32561 —
Not listed Orlando Florida 32804 —
Not listed West Palm Beach Florida 33409 —
Not listed Avon Indiana 46123 —
Not listed Fishers Indiana 46038 —
Not listed Franklin Indiana 46131 —
Not listed Greenfield Indiana 46140 —
Not listed Muncie Indiana 47304 —
Not listed Dubuque Iowa 52001 —
Not listed Dubuque Iowa 52002 —
Not listed Wichita Kansas 67206 —
Not listed Erlanger Kentucky 41018 —
Not listed Henderson Nevada 89052 —
Not listed Charlotte North Carolina 28207 —
Not listed Fargo North Dakota 58103 —
Not listed Cincinnati Ohio 45246 —
Not listed Oklahoma City Oklahoma 73112 —
Not listed Georgetown Texas 78626 —
Not listed Lubbock Texas 79410 —
Not listed San Antonio Texas 78229 —
Not listed Temple Texas 76502 —
Not listed Riverton Utah 84065 —
Not listed Danville Virginia 24541 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01161615, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 17, 2018 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01161615 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →